Can Nicotinamide Adenine Dinucleotide (NAD) lower inflammation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NAD+ and Inflammation: Current Evidence and Recommendations

While NAD+ shows potential anti-inflammatory properties in preclinical studies, there is insufficient clinical evidence to recommend NAD+ supplementation specifically for reducing inflammation in humans.

Mechanism of NAD+ in Inflammation

NAD+ (Nicotinamide Adenine Dinucleotide) plays several roles that may influence inflammatory processes:

  • Functions as both a crucial coenzyme and cosubstrate for various metabolic reactions essential for cell energy homeostasis, survival, and function 1
  • Acts as a modulator of immuno-metabolic circuits, potentially regulating immune responses 1
  • May reduce neuroinflammation through the cGAS-STING pathway, as demonstrated in Alzheimer's disease mouse models 2

Evidence for Anti-inflammatory Effects

Preclinical Evidence

  • In Alzheimer's disease mouse models, treatment with the NAD+ precursor nicotinamide riboside (NR) increased brain NAD+ levels and reduced:

    • Expression of proinflammatory cytokines
    • Activation of microglia and astrocytes
    • NLRP3 inflammasome expression
    • DNA damage and cellular senescence 2
  • NAD+ appears to be involved in the regulation of the cGAS-STING pathway, which is associated with DNA damage and senescence 2

Clinical Evidence

  • A 2024 systematic review of randomized clinical trials found that NAD+ supplementation was associated with:

    • Decrease in inflammatory cytokines in serum and cerebrospinal fluid
    • Improvement in quality of life parameters
    • Low incidence of side effects 3
  • However, the review included only 10 studies with 489 total participants across various clinical conditions, limiting the strength of conclusions 3

Clinical Guidelines and Recommendations

Current guidelines do not support NAD+ supplementation specifically for anti-inflammatory purposes:

  • The American College of Nutrition recommends NAD+ supplementation only for patients with confirmed niacin deficiency or specific medical conditions requiring higher doses 4
  • There are no established clinical indications for general health maintenance, age-related conditions, or weight management due to lack of evidence 4
  • Potential risks of raising NAD+ levels include accumulation of toxic metabolites, tumorigenesis, and promotion of cellular senescence 4

Safety Considerations

  • NAD+ supplementation appears generally well-tolerated with mild side effects 4, 3
  • Common side effects include muscle pain, nervous disorders, fatigue, sleep disturbance, and headaches 3
  • Upper limits for niacin intake:
    • Nicotinic acid: 10 mg/day (due to flushing risk)
    • Nicotinamide: approximately 900 mg/day for adults 4

Alternative Anti-inflammatory Approaches

If inflammation reduction is the goal, consider these evidence-based alternatives:

  • Regular physical activity of 150-300 minutes/week of moderate-intensity activity as recommended by the World Health Organization 4
  • Antioxidant-rich diet with fruits and vegetables to address oxidative stress concerns 4
  • Omega-3 fatty acids have demonstrated anti-inflammatory effects, particularly in reducing inflammation in arthritis 5
  • Reducing omega-6 fatty acid intake may enhance the anti-inflammatory effects of omega-3 supplementation 5

Conclusion

While preclinical evidence suggests NAD+ may have anti-inflammatory properties, current clinical evidence is insufficient to recommend NAD+ supplementation specifically for reducing inflammation. Patients seeking anti-inflammatory interventions should consider established approaches like physical activity, anti-inflammatory diet patterns, and evidence-based supplements under medical supervision.

References

Research

NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING.

Proceedings of the National Academy of Sciences of the United States of America, 2021

Research

Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review.

American journal of physiology. Endocrinology and metabolism, 2024

Guideline

NAD+ Supplementation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.